RKDA · Arcadia Biosciences, Inc.
$0.53
+0.02 (+3.33%)
At close · Aug 28
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company's ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.28M
Shares
2.41M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-13 | 822 | $0.70 | $575 |
| 2026-08-05 | 1,571 | $0.65 | $1,021 |
| 2026-07-28 | 28 | $0.64 | $18 |
| 2026-07-27 | 84 | $0.64 | $54 |
| 2026-07-20 | 169 | $0.67 | $113 |
| 2026-07-17 | 252 | $0.69 | $174 |
| 2026-07-16 | 49 | $0.66 | $32 |
| 2026-07-15 | 79 | $0.62 | $49 |
| 2026-06-22 | 1,814 | $0.78 | $1,415 |
| 2026-06-18 | 1,814 | $0.84 | $1,524 |
| 2026-06-17 | 9,727 | $0.85 | $8,268 |
| 2026-06-16 | 11,605 | $0.92 | $10,677 |
| 2026-06-15 | 36,462 | $1.03 | $37,556 |
| 2026-06-12 | 261,919 | $1.07 | $280,253 |
| 2026-06-11 | 77 | $0.90 | $69 |
| 2026-06-10 | 769 | $0.92 | $707 |
| 2026-06-05 | 7,464 | $1.03 | $7,688 |
| 2026-06-03 | 1,039 | $1.01 | $1,049 |
| 2026-06-01 | 10,518 | $0.96 | $10,097 |
Showing 1–19 of 19 settlements
Key facts
CIK
1469443
CUSIP
039014303
13F (30d)
16 filings
16 filers
Visit website
Investor relations